Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127310871 | 12731087 | 1 | I | 201511 | 20160906 | 20160911 | 20160911 | PER | US-ELI_LILLY_AND_COMPANY-US201609002292 | ELI LILLY AND CO | 72.61 | YR | F | Y | 0.00000 | 20160911 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127310871 | 12731087 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 8 U, TID | U | U | 20563 | 8 | IU | INJECTION | TID | ||||
| 127310871 | 12731087 | 2 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 8 U, TID | 0 | 8 | IU | INJECTION | TID | ||||||
| 127310871 | 12731087 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 8 U, TID | C446949C | 0 | 8 | IU | INJECTION | TID | |||||
| 127310871 | 12731087 | 4 | SS | HUMALOG | INSULIN LISPRO | 1 | Unknown | 8 U, TID | 0 | 8 | IU | INJECTION | TID | ||||||
| 127310871 | 12731087 | 5 | SS | MAGNESIUM | MAGNESIUM | 1 | Unknown | UNK, BID | Y | U | 0 | BID | |||||||
| 127310871 | 12731087 | 6 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | UNK, WEEKLY (1/W) | Y | U | 0 | QD | |||||||
| 127310871 | 12731087 | 7 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | UNK, WEEKLY (1/W) | Y | U | 0 | /wk | |||||||
| 127310871 | 12731087 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 127310871 | 12731087 | 9 | C | FISH OIL | FISH OIL | 1 | U | 0 | |||||||||||
| 127310871 | 12731087 | 10 | C | ATORVASTATIN | ATORVASTATIN | 1 | U | 0 | |||||||||||
| 127310871 | 12731087 | 11 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127310871 | 12731087 | 12 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 127310871 | 12731087 | 13 | C | LOSARTAN. | LOSARTAN | 1 | U | 0 | |||||||||||
| 127310871 | 12731087 | 14 | C | AZOR /00595201/ | ALPRAZOLAM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127310871 | 12731087 | 1 | Type 2 diabetes mellitus |
| 127310871 | 12731087 | 2 | Type 2 diabetes mellitus |
| 127310871 | 12731087 | 5 | Product used for unknown indication |
| 127310871 | 12731087 | 6 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127310871 | 12731087 | Abnormal faeces | |
| 127310871 | 12731087 | Blood glucose abnormal | |
| 127310871 | 12731087 | Dry skin | |
| 127310871 | 12731087 | Epistaxis | |
| 127310871 | 12731087 | Glycosylated haemoglobin increased | |
| 127310871 | 12731087 | Heart rate irregular | |
| 127310871 | 12731087 | Increased appetite | |
| 127310871 | 12731087 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127310871 | 12731087 | 1 | 201607 | 0 | ||
| 127310871 | 12731087 | 2 | 201607 | 0 | ||
| 127310871 | 12731087 | 6 | 201605 | 0 |